Single-Use Systems Market Forecast Points to US$ 15.8 Billion Opportunity by 2031

Market Overview and Growth Outlook

The Single-Use Systems Market size was US$ 6.0 billion in 2024 and is likely to grow to US$ 15.8 billion in 2031. The market forecast shows a robust CAGR of 15.1%, driven by biopharmaceutical demand for flexible, cost-effective, and contamination-controlled manufacturing systems.

“The Single-Use Systems Market is expected to grow at a CAGR of 15.1% during 2025-2031.” Single-use technologies offer flexibility, reduced cross-contamination risk, lower capital and operational expenses, and faster production readiness. These benefits are directly aligned with biologics, vaccines, monoclonal antibodies, and cell and gene therapy production.

Request a free sample report:
https://www.stratviewresearch.com/Request-Sample/single-use-systems-market#form

The strongest market intelligence signal is the shift toward manufacturing platforms that can scale from clinical to commercial production. For readers reviewing the Single-Use Systems Market forecast, demand growth is tied to speed, scalability, containment, and lower validation complexity across bioprocessing operations.

Market Segmentation Analysis

Single-Use Systems Market is segmented by Product Type (Media Bags and Containers, Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Fiber Cartridges, Mixing Systems, Tubing Assemblies, Sampling Systems, and Other Products), by Method Type (Filtration, Cell Culture, Purification, Mixing, and Storage), by Application Type (Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, and Other Applications), by End-User Type (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, and Contract Research Organizations & Manufacturers), and by Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The UK, Spain, Italy, Turkey, and Rest of Europe], China, Rest of Asia-Pacific [Japan, India, Australia, and Others], and Rest of the World [Brazil, Argentina, South Africa, and Others]).

In product type, media bags and containers are likely to be the dominant product category. Bioreactor is estimated to witness the fastest growth in the coming years. This indicates demand for solutions that can support flexible processing, scale-up efficiency, and reduced batch-to-batch contamination risk.

In method type, filtration is anticipated to remain the dominant segment, while purification is estimated to witness the fastest growth. Filtration supports impurity removal, product purity, scale-up efficiency, and compliance, making it a critical unit operation in biologics and vaccine manufacturing.

In application type, monoclonal antibody production is expected to remain the dominant segment. Patient-specific cell therapies are estimated to be the fastest-growing segment. This demand pattern reflects the role of single-use systems in both established large-scale applications and flexible therapy-specific production environments.

In end-user type, biopharmaceutical manufacturers are anticipated to remain the dominant category during the forecast period. Contract research organizations & manufacturers are likely to witness the fastest growth. This shows adoption across both direct producers and outsourced manufacturing partners.

Regional Market Insights

North America is anticipated to be the dominant region during the forecast period. The market’s regional strength is supported by an advanced biopharmaceutical industry, strong regulatory support, high R&D expenditures, rapid innovation, and use of new biopharmaceutical production technologies.

China is expected to emerge as the fastest-growing market. Rising healthcare expenditure and the active presence of major companies such as Danaher Corporation, Merck KGaA, Sartorius AG, and Thermo Fischer Scientific, Inc. support this regional outlook.

Emerging Trends Shaping the Single-Use Systems Market

A major trend is increasing use of disposable components in biopharmaceutical manufacturing and processing. Single-use systems allow companies to adjust production capabilities based on demand without extensive facility modifications, making them important for flexible manufacturing strategies.

Another trend is the growing importance of early-stage R&D and clinical trials. Single-use systems are particularly beneficial in these environments because scalability, speed, and containment are critical for development-stage biopharmaceutical programs.

The market is also influenced by automation, digitization, and sustainability initiatives. Process control, traceability, and compliance are improving, while vendors are developing recyclable or lower-waste SUS products to address sustainability priorities within the industry.

Key Growth Drivers of the Market

• Growing demand for biologics is increasing the need for systems compatible with monoclonal antibodies, vaccines, and cell & gene therapies.

• Faster time-to-market is driving adoption because single-use systems reduce setup and validation times.

• Lower capital and operational expenses support cost-effectiveness across biopharmaceutical production environments.

• Reduced risk of cross-contamination improves process reliability in applications requiring containment and product integrity.

• Increasing adoption by CDMOs and small biotech firms expands the demand base for scalable and flexible manufacturing systems.

Competitive Landscape

Top Companies in the Market

Sartorius AG
Danaher Corporation
Thermo Fisher Scientific Inc.
Merck KGaA

Conclusion and Strategic Outlook

The Single-Use Systems Market is likely to reach US$ 15.8 billion in 2031, expanding from US$ 6.0 billion in 2024 at a CAGR of 15.1%. The market outlook is supported by biologics demand, faster time-to-market, cost-effectiveness, and reduced contamination risk.

Strategically, single-use systems are becoming central to flexible biopharmaceutical manufacturing. Their role across clinical, commercial, and outsourced production models positions the market for sustained relevance in bioprocessing and biotechnology manufacturing ecosystems.

FAQs – Single-Use Systems Market

What is the Single-Use Systems Market forecast?

The Single-Use Systems Market is likely to reach US$ 15.8 billion in 2031. It was valued at US$ 6.0 billion in 2024.

What CAGR is expected during the forecast period?

The Single-Use Systems Market is expected to grow at a CAGR of 15.1% during 2025-2031. This CAGR reflects robust long-term demand.

What is driving the Single-Use Systems Market?

The market is driven by biologics demand, faster time-to-market, cost-effectiveness, reduced cross-contamination risk, and adoption by CDMOs and small biotech firms. These factors improve scalability and manufacturing flexibility.

Which region has the strongest demand?

North America is anticipated to be the dominant region in the Single-Use Systems Market. China is expected to be the fastest-growing market.

What are the risks or investment considerations?

The source page does not explicitly state specific risks or challenges. The investment outlook is supported by the market’s 15.1% CAGR and US$ 15.8 billion forecast by 2031.